Table 4 Factors associated with risk of MGUS progression.
Univariate | Univariatea | Multivariableb | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | Event | HR | 95% CI | P | N | Event | HR | 95% CI | P | HRa | 95% CI | P | |
BMI (≥25) | |||||||||||||
Overall | 555 | 56 | 2.14 | 1.05–4.36 | 0.04 | 446 | 49 | 2.07 | 0.97–4.42 | 0.06 | 1.92 | 0.90–4.11 | 0.09 |
Male | 282 | 33 | 1.39 | 0.57–3.36 | 0.47 | 223 | 27 | 1.21 | 0.46–3.21 | 0.70 | 1.13 | 0.42–2.99 | 0.81 |
Female | 273 | 23 | 3.55 | 1.06–11.9 | 0.041 | 223 | 22 | 3.49 | 1.03–11.8 | 0.044 | 3.46 | 1.02–11.8 | 0.047 |
Isotype (non-IgG) | |||||||||||||
Overall | 580 | 56 | 2.84 | 1.68–4.80 | 0.0001 | 446 | 49 | 3.22 | 1.83–5.65 | <0.0001 | 3.17 | 1.79–5.60 | <0.0001 |
Male | 290 | 33 | 2.50 | 1.25–4.99 | 0.01 | 223 | 27 | 2.64 | 1.22–5.70 | 0.01 | 2.99 | 1.17–5.71 | 0.02 |
Female | 290 | 23 | 3.44 | 1.52–7.82 | 0.003 | 223 | 22 | 4.11 | 1.77–9.58 | 0.001 | 3.79 | 1.58–9.07 | 0.003 |
M protein (≥1.5 g/dl) | |||||||||||||
Overall | 556 | 55 | 2.57 | 1.50–4.42 | 0.001 | 446 | 49 | 2.50 | 1.41–4.45 | 0.002 | 2.22 | 1.23–3.99 | 0.008 |
Male | 285 | 33 | 2.03 | 0.99–4.20 | 0.055 | 223 | 27 | 1.70 | 0.75–3.90 | 0.21 | 1.64 | 0.70–3.84 | 0.26 |
Female | 271 | 22 | 3.64 | 1.57–8.41 | 0.003 | 223 | 22 | 3.84 | 1.66–8.86 | 0.002 | 3.20 | 1.36–7.55 | 0.008 |
FLCr (Abnormal) | |||||||||||||
Overall | 520 | 53 | 3.39 | 1.98–5.82 | <0.0001 | 446 | 49 | 3.49 | 1.99–6.12 | <0.0001 | 2.58 | 1.45–4.59 | 0.001 |
Male | 262 | 30 | 2.32 | 1.13–4.77 | 0.023 | 223 | 27 | 2.47 | 1.16–5.29 | 0.02 | 1.96 | 0.89–4.32 | 0.10 |
Female | 258 | 23 | 5.72 | 2.42–13.5 | <0.0001 | 223 | 22 | 5.47 | 2.29–13.1 | 0.0001 | 3.97 | 1.64–9.59 | 0.002 |
C-statistic | |||||||||||||
Overall | 0.75 | 0.68–0.82 | |||||||||||
Male | 0.71 | 0.60–0.82 | |||||||||||
Female | 0.81 | 0.72–0.90 | |||||||||||